The positive growth factors for elastomeric infusion system market is increase in adoption, growing demand for small disposable infusion pumps, and its wide range of application in various fluid drug delivery systems. In addition, increase in number of surgeries as a result of increased rate of hospitalization that ultimately increases the demand for elastomeric pumps for postoperative pain management conditions. Elastomeric infusion pump system offers several advantages over electronic pumps including portability, feasible demonstration, low weight, size, ease of use, and less interference with sleep. However, difficulties in detection of delivery rate accuracy, and abnormal drug delivery are restraining factors for growth of the market. Furthermore, increasing R&D costs and frequent product recalls, mostly due to design flaws, are expected to hamper the elastomeric infusion system market.A sample of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-elastomeric-infusion-system-market/#ulp-4H8Z4LpNMLEuOnnx[/URL]
Elastomeric infusion system market has been segmented on the basis of product type, indication and end-user
Based on product type, elastomeric infusion system market is segmented into
Continuous Rate Elastomeric Infusion System
Variable Rate Elastomeric Infusion System
Based on indication, elastomeric infusion system market is segmented into
Pain Management
Infectious Disease treatment
Inversional Chemotherapy
Iron Chelation
Based on end-user, elastomeric infusion system market is segmented into
Hospitals
Ambulatory Surgical centres
Homecare Settings
To view TOC of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-elastomeric-infusion-system-market/#ulp-c654SbFYO64MsOhu[/URL]
Elastomeric infusion system market is expected to show significant growth rate owing to rise in demand for disposable ambulatory infusion pumps. Market players are actively participating in innovative strategies to expand their market share. For instance in April 2017, B. Braun Medical Inc. launched “esaypump home infusion therapy app”, offers educational content to clinicians and patients on safe usage of B. Braun Medical’s easypump elastomeric infusion pump. Furthermore, companies are focusing on collaborations and mergers & acquisitions to expand their market share. For instance, in January 2015, Fresenius Kabi (Fresenius SE & Co. KGaA) entered into multiyear distribution agreement with Halyard Health to distribute Halyard Health’s disposable elastomeric intravenous infusion pumps. By this agreement Fresenius Kabi expanded the product portfolio.
Need more information about this report @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-elastomeric-infusion-system-market/#ulp-14mlyhjMGhVjZqa3[/URL]
Some of the players in elastomeric infusion system Market includes B. Braun Holding GmbH & Co. KG (Braun Melsungen AG.) (Germany), Fresenius SE & Co. KGaA (Fresenius Kabi AG) (Germany), Halyard Health, Inc. (U.S.), Leventon S.A.U (Spain), Ambu A/S (Denmark), Baxter International Inc. (U.S.), Nipro Corporation (Japan), and Woo Young Medical Co. (Jincheon) to name a few.
"Precision Business Insights,
Email: sales@precisionbusinessinsights.com
Toll Free(US): +1-866-598-1553"